Improve Medical Instruments Co., Ltd. (300030.SZ)

CNY 6.6

(-2.37%)

Market Cap (In CNY)

2.04 Billion

Revenue (In CNY)

644.62 Million

Net Income (In CNY)

-63.2 Million

Avg. Volume

18.91 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.31-8.3
PE
-
EPS
-
Beta Value
0.377
ISIN
CNE100000JL3
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Guanhua Deng
Employee Count
-
Website
https://www.improve-medical.com
Ipo Date
2009-12-25
Details
Improve Medical Instruments Co., Ltd. provides technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. Its principal products include IMPROVACUTER evacuated blood collection systems, IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, etc. The company also provides blood collection needles, pulsewave blood pressure monitors, thrombosis viscoelastic analysis systems, feces analysis systems, blood collection tube preparation systems, graphic user interface devices, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels. The company was formerly known as Guangzhou Improve Medical Instruments Co., Ltd. Improve Medical Instruments Co., Ltd. was founded in 1996 and is headquartered in Guangzhou, China.